女性与男性腺瘤切除后结直肠癌长期发病率与死亡率
女性结直肠癌发病率升高更明显(SIR 1.64),男性SIR 1.12;女性结直肠癌死亡率升高(SMR 1.13),男性降低(SMR 0.79)。提示腺瘤切除后监测策略应考虑性别差异。
要点
- 女性腺瘤切除后结直肠癌发病率升高幅度大于男性(SIR 1.64 vs 1.12)。
- 女性腺瘤切除后结直肠癌死亡率升高(SMR 1.13),男性降低(SMR 0.79)。
- 女性高危腺瘤者结直肠癌死亡风险升高(SMR 1.37),男性低危腺瘤者降低(SMR 0.70)。
核心结论
- 腺瘤切除后女性结直肠癌死亡风险较一般女性人群升高,而男性较一般男性人群降低。
- 应考虑按性别制定腺瘤切除后的监测建议。
研究设计与样本
- 以女性、男性一般人群为参照,计算结直肠癌标准化发病比(SIR)和基于发病的死亡率比(SMR)及95%CI。
- 高危腺瘤定义为≥2个腺瘤、绒毛成分或高级别异型增生。
主要发现
- 中位随访13.0年,女性1079例(5.5%)和男性866例(4.2%)发生结直肠癌。
- 女性328例(1.7%)和男性275例(1.3%)死于结直肠癌。
- 结直肠癌发病率女性SIR 1.64(95%CI 1.54-1.74),男性SIR 1.12(95%CI 1.05-1.19)。
- 结直肠癌死亡率女性SMR 1.13(95%CI 1.02-1.26),男性SMR 0.79(95%CI 0.71-0.89)。
关键数值与推荐
- 女性高危腺瘤者结直肠癌死亡SMR 1.37(95%CI 1.19-1.57)。
- 女性低危腺瘤者结直肠癌死亡SMR 0.90(95%CI 0.76-1.07)。
- 男性高危腺瘤者结直肠癌死亡SMR 0.89(95%CI 0.76-1.04)。
- 男性低危腺瘤者结直肠癌死亡SMR 0.70(95%CI 0.59-0.84)。
临床怎么用
- 腺瘤切除后监测策略可考虑性别差异,女性尤其高危腺瘤者需关注结直肠癌死亡风险升高。
- 男性腺瘤切除后结直肠癌死亡风险较一般男性人群降低,监测强度可结合个体风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women and men with colorectal adenomas are at increased risk of colorectal cancer and colonoscopic surveillance is recommended. However, the long-term cancer risk remains unknown. AIMS: To investigate colorectal cancer incidence and mortality after adenoma removal in women and men METHODS: We identified all individuals who had adenomas removed in Norway from 1993 to 2007, with follow-up through 2018. We calculated standardized incidence ratios (SIR) and incidence-based mortality ratios (SMR) with 95% confidence intervals (CI) for colorectal cancer in women and men using the female and male population for comparison. We defined high-risk adenomas as ≥2 adenomas, villous component, or high-grade dysplasia. RESULTS: The cohort comprised 40 293 individuals. During median follow-up of 13.0 years, 1079 women (5.5%) and 866 men (4.2%) developed colorectal cancer; 328 women (1.7%) and 275 men (1.3%) died of colorectal cancer. Colorectal cancer incidence was more increased in women (SIR 1.64, 95% CI 1.54-1.74) than in men (SIR 1.12, 95% CI 1.05-1.19). Colorectal cancer mortality was increased in women (SMR 1.13, 95% CI 1.02-1.26) and reduced in men (SMR 0.79, 95% CI 0.71-0.89). Women with high-risk adenomas had an increased risk of colorectal cancer death (SMR 1.37, 95% CI 1.19-1.57); women with low-risk adenomas (SMR 0.90, 95% CI 0.76-1.07) and men with high-risk adenomas had a similar risk (SMR 0.89, 95% CI 0.76-1.04), while men with low-risk adenomas had reduced risk (SMR 0.70, 95% CI 0.59-0.84). CONCLUSIONS: After adenoma removal, women had an increased risk of colorectal cancer death, while men had reduced risk, compared to the general female and male populations. Sex-specific surveillance recommendations after adenoma removal should be considered.
引用
- Jodal HC, Klotz D, Herfindal M, et al. Long-term colorectal cancer incidence and mortality after adenoma removal in women and men. Aliment Pharmacol Ther. 2021. PMID: 34716941. doi:10.1111/apt.16686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。